醫(yī)學(xué)課件腎動(dòng)脈支架植入術(shù)詳解_第1頁(yè)
醫(yī)學(xué)課件腎動(dòng)脈支架植入術(shù)詳解_第2頁(yè)
醫(yī)學(xué)課件腎動(dòng)脈支架植入術(shù)詳解_第3頁(yè)
醫(yī)學(xué)課件腎動(dòng)脈支架植入術(shù)詳解_第4頁(yè)
醫(yī)學(xué)課件腎動(dòng)脈支架植入術(shù)詳解_第5頁(yè)
已閱讀5頁(yè),還剩55頁(yè)未讀, 繼續(xù)免費(fèi)閱讀

下載本文檔

版權(quán)說(shuō)明:本文檔由用戶提供并上傳,收益歸屬內(nèi)容提供方,若內(nèi)容存在侵權(quán),請(qǐng)進(jìn)行舉報(bào)或認(rèn)領(lǐng)

文檔簡(jiǎn)介

1、Clinical Indications(Procedures)Clinical Indications(ProcedurAnatomyAnatomyKidney anatomyKidney anatomyEndovascular Treatment of Renal Artery StenosesAim of the treatment1) Renovascular Hypertension 2) Renal InsufficiencyEndovascular Treatment of RenaRenovascular Hypertension5% of all hypertensive p

2、atientsDue to atherosclerosis or FMDDiagnosed after Surgical follow-up or PTRA.PTRA does not cure Essential Hypertension Renovascular Hypertension5% ofRenal InsufficiencyNephrosclerosis after RAS or occlusionPTRA is indicated to reverse or prevent the decline of kidney functions8cm long kidney is th

3、e lower limit after which kidney function might be compromisedRenal InsufficiencyNephrosclerIndications for PTRAFailed medical therapyReducing drug treatmentPressure gradient 10%More than 50% stenosisAssymmetrical loss of renal massIndications for PTRAFailed medEndovascular Treatment of Renal Artery

4、 Stenoses1) Treatment of artheriosclerotic ostial lesions (80%) dilatation + stenting2) Treatment of post ostial lesions dilatation (stenting if necessary)3) Treatment FMD dilatation (stenting if necessary)Endovascular Treatment of RenaPost-ostial lesionPost-ostial lesionFibro-Muscular DysplasiaFibr

5、o-Muscular DysplasiaFibro-Muscular DysplasiaFibro-Muscular DysplasiaRestenosis after stentingRecent studies have indicated rates are between 10-20% (much better than the 30% with just PTA).Restenosis after stentingReceTreatment OptionsMedical TreatmentPTA with StentingSurgeryDialysis: Renal Function

6、 never get betterTreatment OptionsMedical TreatGold standard treatment todayMedical treatmentACE inhibitors and a new class of Angiotensin receptor blockers Gold standard treatment todayEndovascular Options: PTA or Stenting ?1999: Peter Van de Ven, randomized trialPTA vs Stenting in ostial lesionPTA

7、StentingNumber of patients4243Primary patency rate29%75%Primary success rate57%88%Restenosis post-procedure48%14%Endovascular Options: PTA or SLiteratureLiteratureProduct Strategies014”Cardiologist, Radiologists, Vasc Surgeons.Balloon: M3 RxStents: Corinthian IQ on M3Wire, Stabilizer 7-8F Vista Brit

8、e Tip or IG035 Radiologist who are used to traditional PTA balloons, More range in PTA balloonsBalloons: P3, Opta ProStents: Genesis premounted on OPTA -PROWire 035, Jindo, Storq8F Vista brite Tip or IGProduct Strategies014”035 A new approach: .018 !A GOOD COMPROMISE !Radiologist who are used to tra

9、ditional PTA balloons, More range in PTA balloonsBalloons: SlalomStent: Genesis premounted on OPTA -PROWire 018, SV6-7F Vista brite Tip or IGA new approach: .018 !A GOOD CAdvantages of .014 systemsLess spasm with .014 wireLess wire lengthSmaller puncture siteStent protected by GCGood supportAdvantag

10、es of .014 systemsEndovascular Treatment of Renal Artery Stenoses Through the groin using 8F materialsCan be downsized to 7F using M3Endovascular Treatment of Rena醫(yī)學(xué)課件腎動(dòng)脈支架植入術(shù)詳解Emerald .035Emerald .035Emerald .035 + Pigtail Tempo 4-5F 65cmEmerald .035 + Pigtail Tempo 4Emerald .035 + Renal Curve Temp

11、o 4F 65cmEmerald .035 + Renal Curve TemEmerald .035 + Renal Curve Tempo 4F 65cmEmerald .035 + Renal Curve TemEmerald .035 + RDC Vista Brite Tip 8F 55cmEmerald .035 + RDC Vista BriteEmerald .035 + RDC VBT 8F 55cm + Opta ProEmerald .035 + RDC VBT 8F 55cmEmerald .035 + RDC VBT 8F 55cm + Opta ProEmerald

12、 .035 + RDC VBT 8F 55cmEmerald .035 + RDC VBT 8F 55cm + Opta ProEmerald .035 + RDC VBT 8F 55cmEmerald .035 + RDC VBT 8F 55cmEmerald .035 + RDC VBT 8F 55cmEmerald .035 + RDC VBT 8F 55cm + Corinthian IQ on Opta ProEmerald .035 + RDC VBT 8F 55cmEmerald .035 + RDC VBT 8F 55cm + Corinthian IQ on Opta Pro

13、Emerald .035 + RDC VBT 8F 55cmEmerald .035 + RDC VBT 8F 55cm + Corinthian IQ on Opta ProEmerald .035 + RDC VBT 8F 55cmEmerald .035 + RDC VBT 8F 55cm + Corinthian IQ on Opta ProEmerald .035 + RDC VBT 8F 55cmEmerald .035 + RDC VBT 8F 55cm + Corinthian IQEmerald .035 + RDC VBT 8F 55cmEndovascular Treat

14、ment of Renal Artery Stenoses2) Through the groin using the new 6F materialsEndovascular Treatment of Rena醫(yī)學(xué)課件腎動(dòng)脈支架植入術(shù)詳解.014 Stabilizer.014 Stabilizer.014 Stabilizer + 6F Brite Tip Sheath 55cm.014 Stabilizer + 6F Brite Tip.014 Stabilizer + 6F BTS 55cm +RDC Tempo 4F.014 Stabilizer + 6F BTS 55cm .014

15、Stabilizer + 6F BTS 55cm +RDC Tempo 4F.014 Stabilizer + 6F BTS 55cm .014 Stabilizer + 6F BTS 55cm +RDC Tempo 4F.014 Stabilizer + 6F BTS 55cm .014 Stabilizer + 6F BTS 55cm +RDC Tempo 4F.014 Stabilizer + 6F BTS 55cm .014 Stabilizer + 6F BTS 55cm + M3.014 Stabilizer + 6F BTS 55cm .014 Stabilizer + 6F B

16、TS 55cm + M3.014 Stabilizer + 6F BTS 55cm .014 Stabilizer + 6F BTS 55cm + Corinthian IQ on M3.014 Stabilizer + 6F BTS 55cm .014 Stabilizer + 6F BTS 55cm + Corinthian IQ.014 Stabilizer + 6F BTS 55cm Endovascular Treatment of Renal Artery Stenoses3) Through a brachial accessEndovascular Treatment of R

17、enaTempo 4F MP + .014 StabilizerTempo 4F MP + .014 StabilizerBrite Tip Sheath 6F 90cm + .014 StabilizerBrite Tip Sheath 6F 90cm + .01Brite Tip Sheath 6F 90cm + .014 StabilizerBrite Tip Sheath 6F 90cm + .01Brite Tip Sheath 6F 90cm + RDC Tempo 4F +.014 StabilizerBrite Tip Sheath 6F 90cm + RDCBTS 6F 90

18、cm +.014 StabilizerBTS 6F 90cm +.014 StabilizerBTS 6F 90cm +.014 Stabilizer + M3BTS 6F 90cm +.014 Stabilizer +BTS 6F 90cm +.014 Stabilizer + M3BTS 6F 90cm +.014 Stabilizer +BTS 6F 90cm +.014 Stabilizer + Corinthian IQ on M3BTS 6F 90cm +.014 Stabilizer +BTS 6F 90cm +.014 Stabilizer + Corinthian IQ on M3BTS 6F 90cm +.014 Stabilizer +

溫馨提示

  • 1. 本站所有資源如無(wú)特殊說(shuō)明,都需要本地電腦安裝OFFICE2007和PDF閱讀器。圖紙軟件為CAD,CAXA,PROE,UG,SolidWorks等.壓縮文件請(qǐng)下載最新的WinRAR軟件解壓。
  • 2. 本站的文檔不包含任何第三方提供的附件圖紙等,如果需要附件,請(qǐng)聯(lián)系上傳者。文件的所有權(quán)益歸上傳用戶所有。
  • 3. 本站RAR壓縮包中若帶圖紙,網(wǎng)頁(yè)內(nèi)容里面會(huì)有圖紙預(yù)覽,若沒(méi)有圖紙預(yù)覽就沒(méi)有圖紙。
  • 4. 未經(jīng)權(quán)益所有人同意不得將文件中的內(nèi)容挪作商業(yè)或盈利用途。
  • 5. 人人文庫(kù)網(wǎng)僅提供信息存儲(chǔ)空間,僅對(duì)用戶上傳內(nèi)容的表現(xiàn)方式做保護(hù)處理,對(duì)用戶上傳分享的文檔內(nèi)容本身不做任何修改或編輯,并不能對(duì)任何下載內(nèi)容負(fù)責(zé)。
  • 6. 下載文件中如有侵權(quán)或不適當(dāng)內(nèi)容,請(qǐng)與我們聯(lián)系,我們立即糾正。
  • 7. 本站不保證下載資源的準(zhǔn)確性、安全性和完整性, 同時(shí)也不承擔(dān)用戶因使用這些下載資源對(duì)自己和他人造成任何形式的傷害或損失。

評(píng)論

0/150

提交評(píng)論